Literature DB >> 14573880

Obstructive sarcoidosis.

Petey Laohaburanakit1, Andrew Chan.   

Abstract

Sarcoidosis is a systemic granulomatous disease that frequently involves the lung. Although classically thought of as a restrictive lung disease, airway obstruction has become a recognized feature of the disease in the past years. Sarcoidosis can affect the airway at any level and when the involvement includes small airways, it can resemble more common obstructive airway diseases, such as asthma and chronic bronchitis. Pulmonary function testing and high-resolution computerized tomography of the chest are two important tools to evaluate the presence and extent of airway obstruction in sarcoidosis. Pharmacologic options for the treatment of obstructive sarcoidosis are, in large part, not supported by large, randomized clinical trials. In severe cases of bronchostenosis owing to sarcoidosis granuloma or extrinsic compression from intrathoracic lymphadenopathy, interventional bronchoscopy has successfully been performed, although repeated procedures are usually required. Lung transplantation is an ultimate option in selected patients with late-stage fibrotic disease.

Entities:  

Mesh:

Year:  2003        PMID: 14573880     DOI: 10.1385/CRIAI:25:2:115

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  141 in total

1.  Functional significance of the decreased attenuation sign on expiratory CT in pulmonary sarcoidosis : report of four cases.

Authors:  P Fazzi; P Sbragia; S Solfanelli; S Troilo; C Giuntini
Journal:  Chest       Date:  2001-04       Impact factor: 9.410

Review 2.  Small airway involvement in interstitial lung disease: radiologic evidence.

Authors:  A G Wilcox
Journal:  Curr Opin Pulm Med       Date:  2000-09       Impact factor: 3.155

3.  Transmission of sarcoidosis via cardiac transplantation.

Authors:  W M Burke; A Keogh; P J Maloney; W Delprado; D H Bryant; P Spratt
Journal:  Lancet       Date:  1990 Dec 22-29       Impact factor: 79.321

4.  Airways obstruction in patients with sarcoidosis.

Authors:  J Cieslicki; D Zych; J Zielinski
Journal:  Sarcoidosis       Date:  1991-03

5.  Course and prognosis of sarcoidosis around the world.

Authors:  L E Siltzbach; D G James; E Neville; J Turiaf; J P Battesti; O P Sharma; Y Hosoda; R Mikami; M Odaka
Journal:  Am J Med       Date:  1974-12       Impact factor: 4.965

6.  No evidence for a role of human herpesvirus type 8 in sarcoidosis: molecular and serological analysis.

Authors:  C Lebbé; F Agbalika; B Flageul; C Pellet; M Rybojad; F Cordoliani; D Farge; M D Vignon-Pennamen; J Sheldon; P Morel; F Calvo; T F Schulz
Journal:  Br J Dermatol       Date:  1999-09       Impact factor: 9.302

7.  The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients.

Authors:  A Pietinalho; M Ohmichi; Y Hiraga; A B Löfroos; O Selroos
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  1996-09       Impact factor: 0.670

8.  Treatment of cutaneous and pulmonary sarcoidosis with thalidomide.

Authors:  M Carlesimo; S Giustini; A Rossi; P Bonaccorsi; S Calvieri
Journal:  J Am Acad Dermatol       Date:  1995-05       Impact factor: 11.527

Review 9.  Sarcoidosis: immunopathogenetic concepts and their clinical application.

Authors:  J Müller-Quernheim
Journal:  Eur Respir J       Date:  1998-09       Impact factor: 16.671

10.  Chlamydia pneumoniae DNA is not detectable within sarcoidosis tissue.

Authors:  G D Mills; R K Allen; P Timms
Journal:  Pathology       Date:  1998-08       Impact factor: 5.306

View more
  4 in total

1.  Clinical and Biological Insights from the University of California San Francisco Prospective and Longitudinal Cohort.

Authors:  Bryan S Benn; Zoe Lehman; Sharon A Kidd; Melissa Ho; Sara Sun; Joris Ramstein; Nicholas K Arger; Christine P Nguyen; Robert Su; Antonio Gomez; Jeffrey M Gelfand; Laura L Koth
Journal:  Lung       Date:  2017-07-13       Impact factor: 2.584

2.  Mechanobiology of Pulmonary Diseases: A Review of Engineering Tools to Understand Lung Mechanotransduction.

Authors:  Caymen Novak; Megan N Ballinger; Samir Ghadiali
Journal:  J Biomech Eng       Date:  2021-11-01       Impact factor: 2.097

3.  Lung volumes and airway resistance in patients with a possible restrictive pattern on spirometry.

Authors:  Kenia Schultz; Luiz Carlos D'Aquino; Maria Raquel Soares; Andrea Gimenez; Carlos Alberto de Castro Pereira
Journal:  J Bras Pneumol       Date:  2016 Sep-Oct       Impact factor: 2.624

4.  Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?

Authors:  Julien Guiot; Monique Henket; Anne-Noëlle Frix; Fanny Gester; Marie Thys; Laurie Giltay; Colin Desir; Catherine Moermans; Makon-Sébastien Njock; Paul Meunier; Jean-Louis Corhay; Renaud Louis
Journal:  Respir Res       Date:  2022-04-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.